Home     About SunTech     Business Development
Business Development

Business Development

The future holds enormous promise — for BP technology, for patients and for you. We are continuing our relentless focus on improving noninvasive monitoring. Our investments in R&D are designed to yield devices that make blood pressure measurements more reliable, faster and easier — and to explore other measurement parameters that could have significant medical applications. We are also furthering our partnerships with other forward-looking companies. Building on our successful collaborations with some of the biggest names in the medical device industry, we eagerly anticipate new and innovative opportunities for growth.

Background

SunTech Medical® is a wholly owned subsidiary of SunTech Medical Group Limited (SMG), a privately owned British company. SunTech Medical is involved in the development and marketing of clinical grade blood pressure (BP) measurement devices. The company has become a significant world player in its selected markets. The business operates from bases in Research Triangle Park, NC (USA), Oxford (England) and Shenzhen (China).  SunTech markets its products on a global basis and is the market leader in clinical BP solutions.

Development & Acquisition Plans

SMG is seeking to grow its medical devices business on a threefold platform:

  1. Organic growth of the existing SunTech Medical BP business through the introduction of new products and development of new markets
  2. Utilizing SunTech Medical's core competencies to enter related markets, both established and emerging. Key technology areas of interest include:
    • Continuous BP measurement
    • Central Arterial BP determination
    • Arterial compliance analysis
    • Unique bio-sensor technology
    • DSP algorithms for bio-signal analysis (pattern recognition, noise/artifact reduction etc.)
    • Other non-invasive measurements of cardiovascular parameters
  3. Expansion into non BP medical device sectors through the acquisition of other companies already established in niche markets. Key criteria include
    • Ability to use SMG's existing skills and contacts to leverage position of the acquisition
    • Acquisition candidate has the capability to become a dominant player in its chosen markets
    • Acquisition candidate has the nucleus of a core management team that can achieve the business plan and build a sustainable business

Methods of Achievement

SMG is profitable, cash generative, has funds available and has access to further funding, if required. It is seeking to acquire majority or significant minority stakes in potential acquisitions. For its existing BP business it is willing to consider, joint development programs, licensing-in established technologies and taking minority stakes in early stage companies, in addition to majority holdings.

Contacts

Dayn McBee
CEO SunTech Medical, Inc.
507 Airport Blvd., Suite 117
Morrisville, NC 27560
USA
+1.(919).654.2300
Fax: +1.(919).654.2301
This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Russell Woolley
CEO SunTech Medical Group, Ltd.
Gloucester House
399 Silbury Boulevard
Milton Keynes
Buckinghamshire MK92AH
England
+44.1908.303.660
Fax: +44.8718.133.838
This e-mail address is being protected from spambots. You need JavaScript enabled to view it